Significantly, in the subgroup of patients who experienced aneurysms, 10 (58.8%) patients had a non-truncant PKD1 mutation, 3 (17.6%) had a truncant PKD1 mutation, 1 (5.9%) carried a different mutation from PKD1 or PKD2, and the genetic analysis of 3 (17.6%) was unavailable. Here, PKD2 is linked to aneurysm.